Methylation profiling

Dataset Information

A phase II study of guadecitabien combined with irinotecan vs regorafenib or TAS-102 in previously treated metastatic colorectal cancer patients


ABSTRACT: A phase II study of guadecitabien combined with irinotecan vs regorafenib or TAS-102 in previously treated metastatic colorectal cancer patients

ORGANISM(S): Homo sapiens

PROVIDER: GSE226221 | GEO | 2023/03/31

REPOSITORIES: GEO